Barnaby Balmforth
Directeur Général chez Biofidelity Ltd.
Profil
Barnaby Balmforth is the founder and current Chief Executive Officer of Biofidelity Ltd., a company founded in 2019.
He previously worked as the Chief Operating Officer at Base4 Innovation Ltd.
Dr. Balmforth received an undergraduate degree from the University of Oxford and a doctorate from the University of Cambridge.
Postes actifs de Barnaby Balmforth
| Sociétés | Poste | Début |
|---|---|---|
Biofidelity Ltd.
 Biofidelity Ltd. Miscellaneous Commercial ServicesCommercial Services Biofidelity Ltd. engages in research and experimental development on biotechnology. The company was founded by Barnaby Balmforth and Cameron Frayling on February 15, 2019 and is headquartered in Cambridge, the United Kingdom. | Directeur Général | 15/02/2019 |
Anciens postes connus de Barnaby Balmforth
| Sociétés | Poste | Fin |
|---|---|---|
Base4 Innovation Ltd.
 Base4 Innovation Ltd. Medical SpecialtiesHealth Technology Base4 Innovation Ltd. develops single molecule detection platforms for healthcare and life sciences. The firm develops DNA sequencing using techniques based on silicon chip technology which can easily be scaled up and this high-throughput technology will cut the time and cost of genetic tests, enabling them to be used much more in patient diagnosis and treatment. The company was founded by Cameron Alexander Frayling in 2007 and is headquartered in Cambridge, the United Kingdom. | Directeur des opérations | - |
Formation de Barnaby Balmforth
| University of Oxford | Undergraduate Degree |
| University of Cambridge | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Base4 Innovation Ltd.
Base4 Innovation Ltd. Medical SpecialtiesHealth Technology Base4 Innovation Ltd. develops single molecule detection platforms for healthcare and life sciences. The firm develops DNA sequencing using techniques based on silicon chip technology which can easily be scaled up and this high-throughput technology will cut the time and cost of genetic tests, enabling them to be used much more in patient diagnosis and treatment. The company was founded by Cameron Alexander Frayling in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Biofidelity Ltd.
Biofidelity Ltd. Miscellaneous Commercial ServicesCommercial Services Biofidelity Ltd. engages in research and experimental development on biotechnology. The company was founded by Barnaby Balmforth and Cameron Frayling on February 15, 2019 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
